Growing Concerns of Infertility and Childlessness to Drive Human Reproductive Technologies Market to USD 25.7 Billion by 2020

Growing Concerns of Infertility and Childlessness to Drive Human Reproductive Technologies Market to USD 25.7 Billion by 2020

According to a market research report Human Reproductive Technologies Market 2016-2020 published by iHealthcareAnalyst, Inc., the global human reproductive technologies market is estimated to reach USD 25.7 Billion in 2020, expanding at a CAGR of 5.5% from 2016 to 2020.

Visit the Human Reproductive Technologies Market 2016-2020 report at https://www.ihealthcareanalyst.com/report/human-reproductive-technologies-market/

Human reproductive technology encompasses all current and anticipated uses of technology, including assisted reproductive technology, contraception and others. Assisted reproductive technology (ART) is used to achieve pregnancy in procedures such as fertility medication, artificial insemination, in vitro fertilization and surrogacy, and it is primarily used for infertility treatments. It mainly belongs to the field of reproductive endocrinology and infertility, and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation.

The global human reproductive technologies market report provides market size (Revenue USD Million 2013 to 2020), market share and forecasts growth trends (CAGR%, 2016 to 2020).

The global human reproductive technologies market segmentation is based on product types such as Infertility Drugs – Gonal-F (Recombinant Follitropin Alfa), Follistim AQ (Follitropin Beta), Androgel (Testosterone), Testim (Testosterone), Viagra (Sildenafil Citrate), Cialis (Tadalafil), Levitra/Staxyn (Vardenafil), Infertility Procedure Types – In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Zygote Intrafallopian Transfer (ZIFT), Gamete Intrafallopian Transfer (GIFT), Intrauterine Insemination (IUI), Contraceptive Technology, Drugs – Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives, and Devices – Male Contraceptive Devices (Male Condoms), and Female Contraceptive Devices. The global human reproductive technologies market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global human reproductive technologies market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

  1. Infertility Drugs
    • Gonal-F (Recombinant Follitropin Alfa)
    • Follistim AQ (Follitropin Beta)
    • Androgel (Testosterone)
    • Testim (Testosterone)
    • Viagra (Sildenafil Citrate)
    • Cialis (Tadalafil)
    • Levitra/Staxyn (Vardenafil)
  1. Infertility Procedure Type
    • In Vitro Fertilization (IVF)
    • Intracytoplasmic Sperm Injection (ICSI)
    • Zygote Intrafallopian Transfer (ZIFT)
    • Gamete Intrafallopian Transfer (GIFT)
    • Intrauterine Insemination (IUI)
    • Contraceptive Technology
  1. Contraceptive Drugs
    • Oral Contraceptive Pills
    • Contraceptive Injectables
    • Topical Contraceptives
  1. Contraceptive Devices
    • Male Contraceptive Devices (Male Condoms)
    • Female Contraceptive Devices
  1. Geography (Region, Country)
    • North America (U.S., Canada)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World
  1. Company Profiles
    • Abbott Laboratories, Inc.
    • Actavis, Inc.
    • Bayer AG
    • Church & Dwight, Co. Inc.
    • Cook Medical, Inc.
    • Ferring International Center S.A.
    • Johnson & Johnson
    • Merck & Co., Inc.
    • Merck Serono
    • Pfizer, Inc.
    • Reckitt Benckiser Group plc
    • Teva Pharmaceutical Industries Ltd.
    • Warner Chilcott plc

About Us

iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.

iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.

Contact Us

iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: [email protected]
Website: https://www.ihealthcareanalyst.com

2016-10-14T06:19:12+00:00 Categories: Press Releases|
Translate »